Number of Option Shares if Maximum Option Exercised Advest, Inc. Total 1,250,000 187,500 EXHIBIT A FORM OF LOCK-UP AGREEMENT BANCSHARES OF FLORIDA, INC. LOCK-UP AGREEMENT , 2004 Advest, Inc. as Representative of the Several Underwriters named in Schedule I to the Underwriting Agreement Xxx Xxxxxxxxxxx Xxxxx, 00xx Xxxxx Xxx Xxxx, Xxx Xxxx 00000 Ladies and Gentlemen: The undersigned understands that you, Advest, Inc., as representative (the “Representative”) of the several underwriters named therein (the “Underwriters”), propose to enter into an underwriting agreement (the “Underwriting Agreement”) with Bancshares of Florida, Inc. (the “Company”) providing for the public offering (the “Public Offering”) by the Underwriters of common stock of the Company (the “Common Stock”) pursuant to the Company’s Registration Statement on Form SB-2 (the “Registration Statement”). In consideration of the Underwriting Agreement to purchase and make the Public Offering of the Common Stock, and for other good and valuable consideration, receipt of which is hereby acknowledged, the undersigned hereby agrees, for a period of 180 days after the effective date of the Registration Statement (the “Lock-Up Period”), not to sell, offer to sell, solicit an offer to buy, contract to sell, distribute, pledge or encumber, grant any option for the sale of, or otherwise transfer or dispose of, directly or indirectly, in one or a series of transactions (collectively, a “Disposition”), any shares of Common Stock or any securities convertible or exercisable into or exchangeable for shares of Common Stock (collectively, “Securities”), now owned or hereafter acquired by the undersigned or with respect to which the undersigned has acquired or hereafter acquires the power of disposition, without the prior written consent of the Representative. Prior to the expiration of the Lock-Up Period, the undersigned agrees that it will not announce or disclose any intention to do anything after the expiration of such period which the undersigned is prohibited, as provided in the preceding sentence, from doing during the Lock-Up Period. In addition, for the benefit of the Company and the Underwriters, the undersigned hereby (i) waives any right it may have to cause the Company to register pursuant to the Securities Act of 1933, as amended, any shares of Common Stock now owned or hereafter acquired or received by the undersigned as a result of the Public Offering and (ii) during the Lock-Up Period, agrees not to exercise any such re...
Number of Option Shares. The shares of Common Stock issuable upon exercise of this Warrant are hereinafter referred to as the "Shares." The option described pursuant to this Paragraph 1 shall only be exercisable during the ten (10) year period commencing with the date of the successful completion of the IPO (the "Exercise Period"). The exercise of, or the failure to exercise, this Warrant during the Exercise Period shall terminate all other rights of Holder hereunder.
Number of Option Shares. This Agreement evidences the grant by Catellus to the Executive, on the terms, conditions and restrictions set forth herein and in the Plan, of a non-qualified stock option (the "Option") to purchase, from time to time, a total of 75,000 shares of Common Stock (the "Option Shares").
Number of Option Shares. Public Offering Price per Firm Share: Public Offering Price per Option Share: Underwriting Discount per Firm Share: Underwriting Discount per Option Share: Proceeds to Company per Firm Share (before expenses): Proceeds to Company per Option Share (before expenses): SCHEDULE 2-B Issuer General Use Free Writing Prospectuses None. SCHEDULE 3 List of Lock-Up Parties1 Jxxxx Xxxx Soojae Rxxx Xxx Jxx Xxx Hxxxx Xxx Yusil Yeo 1 NTD: subject to the inclusion of additional parties based on EFH feedback. EXHIBIT A Form of Representative’s Warrant THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) EX XXXXXX, DIVISION OF BENCHMARK INVESTMENTS, LLC OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF EX XXXXXX, DIVISION OF BENCHMARK INVESTMENTS, LLC OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER. THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [ ] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [ ] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING]. CLASS A COMMON STOCK PURCHASE WARRANT For the Purchase of [ ] Shares of Class A Common Stock of Yoshiharu Global Co.
Number of Option Shares. The number of shares of Common Stock and the Strike Price per Option Share pursuant to this Option shall be subject to adjustment from time to time as provided for in this Section 6(a). Notwithstanding anything contained herein, the aggregate Strike Price for the total number of Option Shares issuable pursuant to this Option shall remain unchanged. In case the Company shall at any time change as a whole, by subdivision or combination in any manner or by the making of a stock dividend, the number of outstanding shares of Common Stock into a different number of shares (i.e. forward or reverse stock split), (i) the number of shares which the Holder of this Option shall have been entitled to purchase pursuant to this Option shall be increased or decreased in direct proportion to such increase or decrease of shares, as the case may be, and (ii) the Strike Price per Option Share (but not the aggregate Strike Price) in effect immediately prior to such change shall be increased or decreased in inverse proportion to such increase or decrease of shares, as the case may be.
Number of Option Shares. The Company hereby grants to the Optionee a non-qualified stock option (the “Option”), to purchase two million (2,000,000) shares (the “Option Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”).
Number of Option Shares. 3. Exercise Price Per Share: $ .
Number of Option Shares. Public Offering Price per Firm Share: Public Offering Price per Option Share: Underwriting Discount per Firm Share: Underwriting Discount per Option Share: Proceeds to Company per Firm Share (before expenses): Proceeds to Company per Option Share (before expenses): SCHEDULE 2-B Issuer General Use Free Writing Prospectuses None. SCHEDULE 2-C Written Testing-the-Waters Communications None. SCHEDULE 3 List of Lock-Up Parties Directors and Executive Officers
Number of Option Shares. 8,315,902 (Eight Million Three Hundred Fifteen Thousand Nine Hundred and Two) shares (the “Option Shares”) Expiration Date: 5 years from Grant Date – May 15, 2024
Number of Option Shares. Public Offering Price per Firm Share: $ Public Offering Price per Option Share: $ Underwriting Discount per Firm Share: $ Underwriting Discount per Option Share: $ Proceeds to Company per Firm Share (before expenses): $ Proceeds to Company per Option Share (before expenses): $ SCHEDULE 2-B Issuer General Use Free Writing Prospectuses None. EXHIBIT A Form of Press Release TC BioPharm (Holdings) plc [Date] TC BioPharm (Holdings) plc (the “Company”) announced today that EX Xxxxxx, division of Benchmark Investments, LLC, acting as representative for the underwriters in the Company’s recent public offering of ________ ADSs representing ___________ ordinary shares of the Company, par value £0.01 per share, is [waiving] [releasing] a lock-up restriction with respect to _______ ordinary shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver] [release] will take effect on _______, 20___, and such ordinary shares may be sold on or after such date. This press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended.
